Clinical Pharmacokinetics of Vancomycin
暂无分享,去创建一个
G. Matzke | D. Guay | G. Zhanel | G R Matzke | D R Guay | G G Zhanel
[1] M. Hammeke,et al. Vancomycin therapy for serious staphylococcal infections in chronic hemodialysis patients. , 1980, Journal of dialysis.
[2] D. Sica,et al. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. , 1986, Nephron.
[3] W. J. Martin,et al. Antibiotic Therapy of Bacterial Endocarditis: IV. Successful Short‐Term (Two Weeks) Combined Penicillin‐Dihydrostreptomycin Therapy in Subacute Bacterial Endocarditis Caused by Penicillin‐Sensitive Streptococci , 1953, Circulation.
[4] M. White,et al. Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly. , 1976, Archives of internal medicine.
[5] R. Spears,et al. The use of vancomycin in pediatrics. , 1959, Antibiotics annual.
[6] P. Gilligan,et al. Absorption of oral vancomycin - possible associated toxicity. , 1983, The International journal of pediatric nephrology.
[7] A. Morris,et al. Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. , 1971, The American journal of the medical sciences.
[8] H. Laks,et al. Profound hypotension from rapid vancomycin administration during cardiac operation. , 1984, The Journal of thoracic and cardiovascular surgery.
[9] Mcguire Jm,et al. Vancomycin, a new antibiotic. II. In vitro antibacterial studies. , 1955 .
[10] Arroyo Jc,et al. Accumulation of vancomycin after intraventricular infusions. , 1983 .
[11] R. Griffith. Introduction to vancomycin. , 1981, Reviews of infectious diseases.
[12] L. Lesko,et al. Vancomycin disposition: The importance of age , 1984, Clinical pharmacology and therapeutics.
[13] C. Ray,et al. Vancomycin in perspective. , 1984, American journal of diseases of children.
[14] G. Bodey,et al. Effects of hepatic function on vancomycin clinical pharmacology , 1983, Antimicrobial Agents and Chemotherapy.
[15] I. Phillips,et al. Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular Haemodialysis , 1970, British medical journal.
[16] N. Raichura,et al. Vancomycin: a reappraisal. , 1982, British medical journal.
[17] J. Anhalt,et al. Automated fluorescence polarization immunoassay for monitoring vancomycin. , 1983, Therapeutic drug monitoring.
[18] R. Blouin,et al. Vancomycin pharmacokinetics in normal and morbidly obese subjects , 1982, Antimicrobial Agents and Chemotherapy.
[19] J. Wold,et al. Toxicology of vancomycin in laboratory animals. , 1981, Reviews of infectious diseases.
[20] G. Mccracken,et al. Pharmacology and Efficacy of Vancomycin for Staphylococcal Infections in Children , 1981 .
[21] R. Anderson,et al. Vancomycin, a new antibiotic. V. Distribution, excretion, and renal clearance. , 1956, Antibiotics annual.
[22] M. Finland,et al. Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. , 1971, The Journal of laboratory and clinical medicine.
[23] Kirby Wm,et al. Vancomycin; clinical and laboratory studies. , 1956 .
[24] L. Gentry,et al. Sensitive radioimmunoassay for vancomycin , 1981, Antimicrobial Agents and Chemotherapy.
[25] R. Mackett,et al. Vancomycin-induced neutropenia. , 1985, Canadian Medical Association journal.
[26] T. Sorrell,et al. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. , 1982, Annals of internal medicine.
[27] R. Holliman. "RED MAN SYNDROME" ASSOCIATED WITH RAPID VANCOMYCIN INFUSION , 1985, The Lancet.
[28] W. Keane,et al. Pharmacokinetics of vancomycin in patients with various degrees of renal function , 1984, Antimicrobial Agents and Chemotherapy.
[29] L. Saravolatz,et al. Comparison of fluorescence polarization immunoassay and bioassay of vancomycin , 1984, Journal of clinical microbiology.
[30] J. Rotschafer,et al. Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum , 1983, Journal of clinical microbiology.
[31] P. Traber,et al. Vancomycin Ototoxicity in patient with normal renal function. , 1981, Annals of Internal Medicine.
[32] J. Geraci,et al. Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report. , 1958, Proceedings of the staff meetings. Mayo Clinic.
[33] D. Greenblatt,et al. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. , 1981, Reviews of infectious diseases.
[34] F. Tedesco,et al. ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS , 1978, The Lancet.
[35] William J. Jusko,et al. Berichten , 2005, Pharmaceutisch weekblad.
[36] J. McClain,et al. Vancomycin quantitation by high-performance liquid chromatography in human serum. , 1982, Journal of Chromatography A.
[37] C. Ba,et al. Clinical usefulness of vancomycin. , 1983 .
[38] J. M. Phillips,et al. Vancomycin: a rapid HPLC assay for a potent antibiotic. , 1984, Journal of analytical toxicology.
[39] H. Monteil,et al. Determination of vancomycin in human serum by high-pressure liquid chromatography , 1985, Antimicrobial Agents and Chemotherapy.
[40] C. Comty,et al. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. , 1982, Nephron.
[41] N. Fineberg,et al. Effects of vancomycin on renal function in rats , 1981, Antimicrobial Agents and Chemotherapy.
[42] M. Dudley,et al. Absorption of vancomycin. , 1984, Annals of internal medicine.
[43] R. Blevins,et al. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis , 1984, Antimicrobial Agents and Chemotherapy.
[44] C. N. Walker. Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides , 1980, Antimicrobial Agents and Chemotherapy.
[45] S. Kaplan,et al. Vancomycin pharmacokinetics in premature infants. , 1985, Pediatric pharmacology.
[46] R. Gleckman,et al. Vancomycin. A second look. , 1977, JAMA.
[47] J. Dick,et al. Evaluation of an automated fluorescence polarization immunoassay for vancomycin , 1983, Antimicrobial Agents and Chemotherapy.
[48] J. Uhl,et al. High Performance Liquid Chromatographic Assay of Vancomycin in Serum , 1979, Therapeutic drug monitoring.
[49] P. Elmes,et al. Vancomycin: Report on Treatment of Patients with Severe Staphylococcal Infections , 1959, British medical journal.
[50] G. Eliopoulos,et al. Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis. , 1984, Annals of internal medicine.
[51] S. Rosansky,et al. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis , 1983, Antimicrobial Agents and Chemotherapy.
[52] B. Farber,et al. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 , 1983, Antimicrobial Agents and Chemotherapy.
[53] F. Martí-ibáñez,et al. Antibiotics Annual 1955 - 1956 , 1956 .
[54] N. Benowitz,et al. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. , 1979, Clinical nephrology.
[55] J. S. Murray,et al. Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. , 1966, The New England journal of medicine.
[56] J. Wagner. Significance of ratios of different volumes of distribution in pharmacokinetics , 1983, Biopharmaceutics & drug disposition.
[57] C H Nightingale,et al. Pharmacokinetics of vancomycin in anuria. , 1981, Reviews of infectious diseases.
[58] M. Sande,et al. Penetration of antistaphylococcal antibiotics into the human eye. , 1974, American journal of ophthalmology.
[59] W. Johnson,et al. Vancomycin therapy of bacterial endocarditis. , 1978, The American journal of medicine.
[60] W. Hall,et al. The treatment of severe staphylococcal infections with vancomycin. , 1961, Annals of internal medicine.
[61] G. Alpert,et al. Vancomycin dosage in pediatrics reconsidered. , 1984, American journal of diseases of children.
[62] R. Pfeiffer. Structural features of vancomycin. , 1981, Reviews of infectious diseases.
[63] C. Bryan,et al. Safety of Oral Vancomycin in Functionally Anephric Patients , 1978, Antimicrobial Agents and Chemotherapy.
[64] F. Sklar,et al. Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. , 1984, American journal of diseases of children.
[65] D J Greenblatt,et al. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. , 1981, Annals of internal medicine.
[66] Garrelts Jc,et al. Vancomycin and the "red man's syndrome". , 1985 .
[67] M. Brier,et al. Vancomycin kinetics during continuous ambulatory peritoneal dialysis , 1983, Clinical pharmacology and therapeutics.
[68] D. M. Perry,et al. Treatment of staphylococcal septicemia with vancomycin: report of thirty-three cases. , 1960, The New England journal of medicine.
[69] S. Cortell,et al. Extracorporeal therapy in the treatment of intoxication. , 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[70] R. Griffith,et al. Vancomycin, a new antibiotic. III. Preliminary clinical and laboratory studies. , 1955, Antibiotics annual.
[71] J. Marr,et al. Sterilization of Ommaya reservoir by instillation of vancomycin. , 1981, The American journal of medicine.
[72] B. Cunha,et al. Comparison of Bioassay, High‐Performance Liquid Chromatography, and Fluorescence Polarization Immunoassay for Quantitative Determination of Vancomycin in Serum , 1984, Therapeutic drug monitoring.
[73] R. Khakoo,et al. Gentamicin-resistant Pseudomonas aeruginosa. , 1978, Mayo Clinic proceedings.
[74] B. Ackerman,et al. Vancomycin and red necks. , 1985, Annals of internal medicine.
[75] G. Bodey,et al. Comparison of vancomycin disposition in rats with normal and abnormal renal functions , 1981, Antimicrobial Agents and Chemotherapy.
[76] Mccormick Mh,et al. Vancomycin, a new antibiotic. I. Chemical and biologic properties. , 1955 .
[77] C. Sanders,et al. Vancomycin concentration in human tissues--preliminary report. , 1979, The Journal of antimicrobial chemotherapy.
[78] M. Roizen,et al. Hazards of rapid administration of vancomycin. , 1979, Annals of internal medicine.
[79] H. Tausk,et al. Anaphylactoid reaction to vancomycin during anesthesia: a case report. , 1977, Anesthesia and analgesia.
[80] G. Mccracken,et al. Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.
[81] Matzke Gr,et al. Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage. , 1985 .
[82] P. Murray,et al. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay , 1984, Journal of clinical microbiology.
[83] D. Krogstad,et al. Single‐Dose Kinetics of Intravenous Vancomycin , 1980, Journal of clinical pharmacology.
[84] J. Rotschafer,et al. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations , 1982, Antimicrobial Agents and Chemotherapy.
[85] C. Walker,et al. Sensitive Bioassay for Vancomycin , 1978, Antimicrobial Agents and Chemotherapy.
[86] H. E. Hansen,et al. Peritoneal transport of vancomycin during peritoneal dialysis. , 1979, Nephron.
[87] J. Rotschafer,et al. Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations , 1980, Antimicrobial Agents and Chemotherapy.